SEC Form 4
Tecogen Inc. (TGEN) insider trading
In the 12 months to Nov 20, 2026, 6 TGEN insiders reported open-market purchases of $191.2K across 11 filings; no open-market sales were filed.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $0
- 0 filings · 0 insiders
- Open-market purchases
- $191.2K
- 11 filings
Who traded TGEN, and when
- Purchase
TGEN daily close from Nov 20, 2025 to Nov 20, 2026, between $1.53 and $7.46, last $1.54. 0 sale and 11 purchase filings by 6 insiders, marked at their filing dates. Earl Lewis, Director: bought $46.6K across 3 filings, first filed Mar 27, 2026, last Nov 19, 2026. Susan B. Hirsch, Director: bought $44.1K across 2 filings, first filed Mar 27, 2026, last Apr 14, 2026. John Kimball Whiting IV, General Counsel & Secretary: bought $43.4K across 2 filings, first filed Mar 23, 2026, last Nov 19, 2026. Roger P. Deschenes, CAO → Chief Financial Officer: bought $40.3K across 2 filings, first filed Mar 23, 2026, last Nov 19, 2026. Ahmed Ghoniem, Director: bought $10.0K across 1 filing, first filed Apr 27, 2026, last Apr 27, 2026. Abinand Rangesh, Chief Executive Officer: bought $6.9K across 1 filing, first filed Mar 23, 2026, last Mar 23, 2026.
Largest mark · tap a row for others
Earl Lewis · Director
Filing 1 of 2 within a week · $27,005 total
Purchase $12,596
5,000 shares at $2.52 avg
Filed Mar 27, 2026
Close on filing date $2.57
Earl Lewis · Director
Director
$46.6K boughtSusan B. Hirsch · Director
Director
$44.1K boughtJohn Kimball Whiting IV · General Counsel & Secretary
General Counsel & Secretary
$43.4K boughtRoger P. Deschenes · CAO → Chief Financial Officer
CAO → Chief Financial Officer
$40.3K boughtAhmed Ghoniem · Director
Director
$10.0K boughtAbinand Rangesh · Chief Executive Officer
Chief Executive Officer
$6.9K boughtOpen-market trades
11 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Earl Lewis | Director | — | $46.6K | 3 | — | |
| Susan B. Hirsch | Director | — | $44.1K | 2 | — | |
| John Kimball Whiting IV | General Counsel & Secretary | — | $43.4K | 2 | — | |
| Roger P. Deschenes | CAO → Chief Financial Officer | — | $40.3K | 2 | — | |
| Ahmed Ghoniem | Director | — | $10.0K | 1 | — | |
| Abinand Rangesh | Chief Executive Officer | — | $6.9K | 1 | — |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | Earl Lewis Director | Purchase | 10,000 | $1.96 | $19.6K | 1,021,006 | |
traded | Roger P. Deschenes Chief Financial Officer | Purchase | 10,000 | $1.80 | $18.0K | 91,975 | |
traded | John Kimball Whiting IV General Counsel & Secretary | Purchase | 10,000 | $1.96 | $19.6K | 51,954 | |
traded | Ahmed Ghoniem Director | Purchase | 12,723 | $0.79 | $10.0K | 12,723 | |
traded | Susan B. Hirsch Director | Purchase | 5,000 | $3.73 | $18.7K | 265,416 | |
traded | Earl Lewis Director | Purchase | 5,000 | $2.52 | $12.6K | 1,011,006 | |
traded | Earl Lewis Director | Purchase | 5,000 | $2.88 | $14.4K | 1,006,006 | |
traded | Susan B. Hirsch Director | Purchase | 10,000 | $2.54 | $25.4K | 260,416 | |
traded | Abinand Rangesh Chief Executive Officer | Purchase | 3,000 | $2.30 | $6.9K | 67,193 | |
traded | Roger P. Deschenes CAO | Purchase | 10,000 | $2.23 | $22.3K | 52,962 | |
traded | John Kimball Whiting IV General Counsel & Secretary | Purchase | 10,000 | $2.38 | $23.8K | 22,612 |
GET /stocks/filings/vX/form-4?tickers=TGEN&filing_date.gte=2025-11-20&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"TGEN"
],
"issuer_cik": "0001537435",
"owner_cik": "0001496259",
"accession_number": "0001496259-26-000005",
"form_type": "4",
"filing_date": "2026-11-19",
"period_of_report": "2026-11-18",
"issuer_name": "TECOGEN INC.",
"issuer_trading_symbol": "TGEN",
"owner_name": "Deschenes Roger P.",
"is_director": false,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "Chief Financial Officer",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-11-18",
"transaction_code": "P",
"equity_swap_involved": false,
"transaction_shares": 9700,
"transaction_price_per_share": 1.8,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 91675,
"transaction_value": 17460,
"not_subject_to_section_16": false,
"direct_or_indirect": "D"
},
{
"tickers": [
"TGEN"
],
"issuer_cik": "0001537435",
"owner_cik": "0001230427",
"accession_number": "0001230427-26-000005",
"form_type": "4",
"filing_date": "2026-11-19",
"period_of_report": "2026-11-16",
"issuer_name": "TECOGEN INC.",
"issuer_trading_symbol": "TGEN",
"owner_name": "Lewis Earl",
"is_director": true,
"is_officer": false,
"is_ten_percent_owner": false,
"is_other": false,
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-11-16",
"transaction_code": "P",
"equity_swap_involved": false,
"transaction_shares": 700,
"transaction_price_per_share": 1.95,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 1019800,
"transaction_value": 1365,
"not_subject_to_section_16": false,
"direct_or_indirect": "D"
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 6 records
- Option exercises1 record
- Grants and awards5 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Role
- The title on each filing. Someone whose title changed shows more than one.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
Frequently asked questions
Has Tecogen Inc.'s CEO sold stock?
No. Abinand Rangesh (CEO) made no open-market sales filed as CEO in the last 12 months.
How current is TGEN’s insider data?
These are TGEN Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.
What counts as an open-market buy or sell?
Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.
Build with AI
Track TGEN insider trades with your agent
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for TGEN every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.